The impact of international legal framework - The recognition of second medical use
This paper analyses the impact of international legal framework on the pharmaceutical patent and second medical use.The provisions under the Trade Related Aspects of Intellectual Property Rights(“TRIPS”) Agreement generally focuses on the pharmaceutical patent in relation to the access to medicines...
| Main Authors: | , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://repo.uum.edu.my/id/eprint/13166/1/83.pdf |
| _version_ | 1803626546695503872 |
|---|---|
| author | Shanmugaiah, Kamini Zainol, Zinatul Ashiqin |
| author_facet | Shanmugaiah, Kamini Zainol, Zinatul Ashiqin |
| author_sort | Shanmugaiah, Kamini |
| collection | UUM |
| description | This paper analyses the impact of international legal framework on the pharmaceutical patent and second medical use.The provisions under the Trade Related Aspects of Intellectual Property Rights(“TRIPS”) Agreement generally focuses on the pharmaceutical patent in relation to the access to medicines and not specifically addressing issues on the medical innovation involving first and
second medical use.Although Doha Declaration on the “TRIPS” Agreement and Public Health equally recognizes on the importance of medical innovation, the issue on medical innovation is not further analysed in relation to the second
medical use. The provisions of the “TRIPS” Agreement open a flexible option to the member countries to exclude method of medical treatment from patentability. Although excluding method of medical treatment seems to be as a flexible option
to countries to prevent evergreening patents, it further adds to the challenge of overlooking the importance of the second medical use type of patents.The author will also analyse another important international legal framework on the
European Patent Convention (EPC) which emphasizes on the new uses of known substances.However, the Article 54(5) of the EPC only impliedly recognizes first medical uses.The question on whether EPC recognizes second medical use is still ambiguous in the international legal framework not with standing its importance in the pharmaceutical and medical field. |
| first_indexed | 2024-07-04T05:51:53Z |
| format | Conference or Workshop Item |
| id | uum-13166 |
| institution | Universiti Utara Malaysia |
| language | English |
| last_indexed | 2024-07-04T05:51:53Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | uum-131662015-01-25T01:33:01Z https://repo.uum.edu.my/id/eprint/13166/ The impact of international legal framework - The recognition of second medical use Shanmugaiah, Kamini Zainol, Zinatul Ashiqin RS Pharmacy and materia medica This paper analyses the impact of international legal framework on the pharmaceutical patent and second medical use.The provisions under the Trade Related Aspects of Intellectual Property Rights(“TRIPS”) Agreement generally focuses on the pharmaceutical patent in relation to the access to medicines and not specifically addressing issues on the medical innovation involving first and second medical use.Although Doha Declaration on the “TRIPS” Agreement and Public Health equally recognizes on the importance of medical innovation, the issue on medical innovation is not further analysed in relation to the second medical use. The provisions of the “TRIPS” Agreement open a flexible option to the member countries to exclude method of medical treatment from patentability. Although excluding method of medical treatment seems to be as a flexible option to countries to prevent evergreening patents, it further adds to the challenge of overlooking the importance of the second medical use type of patents.The author will also analyse another important international legal framework on the European Patent Convention (EPC) which emphasizes on the new uses of known substances.However, the Article 54(5) of the EPC only impliedly recognizes first medical uses.The question on whether EPC recognizes second medical use is still ambiguous in the international legal framework not with standing its importance in the pharmaceutical and medical field. 2014-11-29 Conference or Workshop Item PeerReviewed application/pdf en https://repo.uum.edu.my/id/eprint/13166/1/83.pdf Shanmugaiah, Kamini and Zainol, Zinatul Ashiqin (2014) The impact of international legal framework - The recognition of second medical use. In: UUM International Conference on Governance 2014 (ICG), 29th - 30th November 2014, Flamingo Hotel By The Beach, Pulau Pinang. http://www.uumicg2014.com/ |
| spellingShingle | RS Pharmacy and materia medica Shanmugaiah, Kamini Zainol, Zinatul Ashiqin The impact of international legal framework - The recognition of second medical use |
| title | The impact of international legal framework - The recognition of second medical use |
| title_full | The impact of international legal framework - The recognition of second medical use |
| title_fullStr | The impact of international legal framework - The recognition of second medical use |
| title_full_unstemmed | The impact of international legal framework - The recognition of second medical use |
| title_short | The impact of international legal framework - The recognition of second medical use |
| title_sort | impact of international legal framework the recognition of second medical use |
| topic | RS Pharmacy and materia medica |
| url | https://repo.uum.edu.my/id/eprint/13166/1/83.pdf |
| work_keys_str_mv | AT shanmugaiahkamini theimpactofinternationallegalframeworktherecognitionofsecondmedicaluse AT zainolzinatulashiqin theimpactofinternationallegalframeworktherecognitionofsecondmedicaluse AT shanmugaiahkamini impactofinternationallegalframeworktherecognitionofsecondmedicaluse AT zainolzinatulashiqin impactofinternationallegalframeworktherecognitionofsecondmedicaluse |